Ines Schroeder
Impact in
-
- Antibiotic Use and Resistance
Papers in
- Epidemiology 11
- Pneumonia and Respiratory Infections 4
- Sepsis Diagnosis and Treatment 4
- Fungal Infections and Studies 3
-
- COVID-19 Clinical Research Studies 4
- Antifungal resistance and susceptibility 3
- Co-authors
- Michael Zöller (21 shared papers)Christina Scharf (22 shared papers)Michael Irlbeck (16 shared papers)Uwe Liebchen (14 shared papers)Michael Paal (12 shared papers)Michael Vogeser (6 shared papers)Ludwig T. Weckbach (2 shared papers)Johannes C. Hellmuth (2 shared papers)
In The Last Decade
Ines Schroeder
30 papers receiving 525 citations
Peers
Comparison fields: 5 of 74
- Applied Microbiology and Biotechnology 58
- Critical Care and Intensive Care Medicine 58
- Molecular Medicine 45
- Pharmacology 142
- Infectious Diseases 104
Countries citing papers authored by Ines Schroeder
This map shows the geographic impact of Ines Schroeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Schroeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Schroeder more than expected).
Fields of papers citing papers by Ines Schroeder
This network shows the impact of papers produced by Ines Schroeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Schroeder. The network helps show where Ines Schroeder may publish in the future.
Co-authors
The 25 scholars most cited alongside Ines Schroeder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 59 | |
| 2 | 2021 | 58 | |
| 3 | 2008 | 50 | |
| 4 | 2020 | 46 | |
| 5 | 2021 | 44 | |
| 6 | 2021 | 42 | |
| 7 | 2020 | 41 | |
| 8 | 2020 | 35 | |
| 9 | 2021 | 35 | |
| 10 | 2017 | 25 | |
| 11 | 2022 | 22 | |
| 12 | 2019 | 16 | |
| 13 | 2022 | 9 | |
| 14 | 2018 | 9 | |
| 15 | 2022 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2023 | 5 | |
| 18 | 2020 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2021 | 4 |
About Ines Schroeder
Ines Schroeder is a scholar working on Epidemiology, Infectious Diseases, Pharmacology, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 540 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Intensive Care Unit Cognitive Disorders (6 papers), Antibiotic Use and Resistance (5 papers), COVID-19 Clinical Research Studies (4 papers), Pneumonia and Respiratory Infections (4 papers), Sepsis Diagnosis and Treatment (4 papers), Fungal Infections and Studies (3 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (58 citations), Critical Care and Intensive Care Medicine (58 citations), Molecular Medicine (45 citations), Pharmacology (142 citations) and Infectious Diseases (104 citations). Ines Schroeder has collaborated with scholars based in Germany, Ireland and Morocco. Frequent co-authors include Michael Zöller, Christina Scharf, Michael Irlbeck, Uwe Liebchen, Michael Paal, Michael Vogeser, Ludwig T. Weckbach, Johannes C. Hellmuth, Maximilian Muenchhoff and Ulrich Grabmaier. Their work appears in journals such as Journal of Critical Care, Infection, Annals of Intensive Care, Antibiotics and Critical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.